Full name
BLAU FARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ - SPÓŁKA KOMANDYTOWO-AKCYJNA W LIKWIDACJI
uses securityreCAPTCHA
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46 - Wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52 - Warehousing, storage, and support activities for transport
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,8 | 0,1 | -0 | -109,9 |
EBITDA | -0,7 | 0,1 | -0 | -109,8 |
Short time liabilities | 0,4 | 0,4 | 0,5 | 28,1 |
Equity capital | -0,3 | -0,2 | -0,2 | -4,6 |
Operating profit (EBIT) | -0,7 | 0,1 | -0 | -109,8 |
Assets | 0,2 | 0,3 | 0,4 | 38,1 |
Net profit (loss) | -1,8 | 0,1 | -0 | -109,9 |
Cash | 0 | 0,1 | 0 | -84,7 |
Net income from sale | 0,5 | 0,6 | 0,5 | -11,8 |
Liabilities and provisions for liabilities | 0,5 | 0,5 | 0,6 | 24,9 |
Working assets | 0,2 | 0,3 | 0,4 | 38,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 678,5 | -46,6 | 4,4 | 51 |
Equity capital to total assets | -136,7 | -65,5 | -49,6 | 15,9 |
Gross profit margin | -365,9 | 14,1 | -1,6 | -15,7 |
EBITDA Margin | -143,3 | 14,1 | -1,6 | -15,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 292 | 247 | 359 | 112 |
Current financial liquidity indicator | 0.43432125449180603 | 0.604383647441864 | 0.6686312556266785 | 0,1 |
Net dept to EBITDA | 0.018868299201130867 | -0.949960470199585 | 1.475738525390625 | 2,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane